Crescent Biopharma Inc.

NASDAQ: CBIO · Real-Time Price · USD
13.89
-0.04 (-0.29%)
At close: Aug 15, 2025, 3:59 PM
14.06
1.19%
After-hours: Aug 15, 2025, 07:27 PM EDT

Crescent Biopharma Revenue

Crescent Biopharma reported an annual revenue of $105.76M, reflecting a 0% growth. For the quarter ending June 30, 2025, Crescent Biopharma generated $0 in revenue.
Revenue (ttm)
105.76M
Revenue Growth
n/a
Price / Sales Ratio
0.13
Revenue / Employee
15.11M
Employees
7
Market Cap
193.04M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 105.76M +13219.52%
Dec 31, 2022 794K -89.18%
Dec 31, 2021 7.34M -64.97%
Dec 31, 2020 20.95M +Infinity%
Dec 31, 2019 0 -100.00%
Dec 31, 2018 6K -99.41%
Dec 31, 2017 1.02M +155.14%
Dec 31, 2016 399K -77.20%
Dec 31, 2015 1.75M +536.36%
Dec 31, 2014 275K -92.42%
Dec 31, 2013 3.63M -93.73%
Dec 31, 2012 57.86M -40.74%
Dec 31, 2011 97.64M +13.91%
Dec 31, 2010 85.71M +242.00%
Dec 31, 2009 25.06M +24.78%
Dec 31, 2008 20.09M +73.51%
Dec 31, 2007 11.58M -57.96%
Dec 31, 2006 27.54M +2233.86%
Dec 31, 2005 1.18M -68.44%
Dec 31, 2004 3.74M +52.09%
Dec 31, 2003 2.46M +7.52%
Dec 31, 2002 2.29M +34.23%
Dec 31, 2001 1.7M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.